Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning
G Grandi, R De Fata, F Varliero… - Gynecological …, 2020 - Taylor & Francis
Objective Current research informations fail to adequately inform about when levonorgestrel-
releasing intrauterine system (LNG-IUS) 52 mg is used instead of other lower dose LNG …
releasing intrauterine system (LNG-IUS) 52 mg is used instead of other lower dose LNG …
Recent developments in the clinical use of the levonorgestrel‐releasing intrauterine system
K GEMZELL‐DANIELSSON, P Inki… - Acta obstetricia et …, 2011 - Wiley Online Library
This overview focuses on recent developments in the clinical use of the levonorgestrel‐
releasing intrauterine system (LNG‐IUS) on established indications. Recent studies confirm …
releasing intrauterine system (LNG‐IUS) on established indications. Recent studies confirm …
The effect of age, parity and body mass index on the efficacy, safety, placement and user satisfaction associated with two low-dose levonorgestrel intrauterine …
K Gemzell-Danielsson, D Apter, B Hauck, T Schmelter… - PloS one, 2015 - journals.plos.org
Objective Two low-dose levonorgestrel intrauterine contraceptive systems (LNG-IUSs; total
content 13.5 mg [average approx. 8 μg/24 hours over the first year; LNG-IUS 8] and total …
content 13.5 mg [average approx. 8 μg/24 hours over the first year; LNG-IUS 8] and total …
A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an …
G Fan, S Kang, M Ren, E Weisberg, E Lukkari-Lax… - Contraception, 2017 - Elsevier
Objective The objective was to evaluate the efficacy and safety of a low-dose levonorgestrel
intrauterine system with total content 13.5 mg (average approximately 8 μg/24 h over the first …
intrauterine system with total content 13.5 mg (average approximately 8 μg/24 h over the first …
Levonorgestrel-releasing intrauterine system–the discontinuing story
AAA Ewies - Gynecological Endocrinology, 2009 - Taylor & Francis
Levonorgestrel-releasing Intrauterine System (LNG-IUS) is licensed for use as a
contraceptive, for the treatment of heavy menstrual bleeding and during estrogen …
contraceptive, for the treatment of heavy menstrual bleeding and during estrogen …
[HTML][HTML] Immediate versus delayed insertion of the levonorgestrel intrauterine device in postpartum adolescents: a randomized pilot study
R Soon, K McGuire, J Salcedo… - Hawai'i Journal of …, 2018 - ncbi.nlm.nih.gov
This pilot study assessed the feasibility of conducting a larger randomized controlled trial
comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG …
comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG …
Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey
S Zhao, J Deng, Y Wang, S Bi, X Wang… - Patient preference …, 2014 - Taylor & Francis
Background Although surveys conducted in Western countries have shown that the
levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena®) is well accepted by …
levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena®) is well accepted by …
General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK
AJ Middleton, J Naish, N Singer - The European Journal of …, 2011 - Taylor & Francis
Background and objectives The levonorgestrel-releasing intrauterine system (LNG-IUS,
Mirena®) is one of the most reliable and cost-effective methods of contraception. In the UK …
Mirena®) is one of the most reliable and cost-effective methods of contraception. In the UK …
Evidence-based selection of candidates for the levonorgestrel intrauterine device (IUD)
LS Callegari, BG Darney, EM Godfrey… - The Journal of the …, 2014 - Am Board Family Med
Background: Recent evidence-based guidelines expanded the definition of appropriate
candidates for the levonorgestrel-releasing intrauterine system (LNG-IUS). We investigated …
candidates for the levonorgestrel-releasing intrauterine system (LNG-IUS). We investigated …
Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system
B Seeber, SC Ziehr, A Gschlieβer, C Moser, V Mattle… - Contraception, 2012 - Elsevier
BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is well
accepted as an easy-to-use contraceptive with an excellent side-effect profile. It contains a …
accepted as an easy-to-use contraceptive with an excellent side-effect profile. It contains a …